Related Experiment Video

Updated: Jul 19, 2025

Author Spotlight: Assessing the Feasibility of Using Amplitude-Integrated EEG During Neonatal Transport
05:15

Author Spotlight: Assessing the Feasibility of Using Amplitude-Integrated EEG During Neonatal Transport

Published on: June 21, 2024

742

Treatment of Seizures in the Neonate: Special Report From the ILAE Task Force on Neonatal Seizures, 2022

Mamta Jajoo1, Pratima Anand2, Gouri Rao Passi3

  • 1Divison of Neonatology, Department of Paediatrics, Chacha Nehru Bal Chikitsalaya, New Delhi.

Indian Pediatrics
|August 11, 2023
PubMed

Insights

New International League Against Epilepsy (ILAE) guidelines offer updated treatment recommendations for neonatal seizures. Pediatricians can use these practical guidelines for improved clinical decision-making in managing infant epilepsy.

Area of Science:

  • Neurology
  • Pediatrics
  • Epileptology

Background:

  • Neonatal seizures require timely and effective management.
  • Previous guidelines from the World Health Organization (WHO) and ILAE were published in 2011.
  • Advances in understanding and treating neonatal seizures necessitate updated recommendations.

Purpose of the Study:

  • To summarize the draft guidelines and consensus-based recommendations for neonatal seizure treatment.
  • To highlight changes in management compared to the 2011 WHO ILAE guidelines.
  • To provide practical decision-making support for pediatricians managing neonatal seizures.

Main Methods:

  • Review and synthesis of the International League Against Epilepsy (ILAE) task force's draft guidelines.
  • Comparative analysis of new recommendations against the previous 2011 WHO ILAE guidelines.
  • Focus on practical applicability for pediatricians.

Main Results:

  • The ILAE task force has released draft guidelines for neonatal seizure treatment.
  • These recommendations represent an update from the 2011 WHO ILAE guidelines.
  • Emphasis is placed on actionable steps for pediatricians.

Conclusions:

  • The new ILAE draft guidelines provide an updated framework for neonatal seizure management.
  • Pediatricians are equipped with revised recommendations for practical clinical application.
  • These guidelines aim to standardize and improve the care of infants with seizures.

More Related Videos

Continuous Video Electroencephalogram during Hypoxia-Ischemia in Neonatal Mice09:29

Continuous Video Electroencephalogram during Hypoxia-Ischemia in Neonatal Mice

Published on: June 11, 2020

3.4K
Preterm EEG: A Multimodal Neurophysiological Protocol19:32

Preterm EEG: A Multimodal Neurophysiological Protocol

Published on: February 18, 2012

28.5K

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
413
Arteries of the Lower Limbs01:24

Arteries of the Lower Limbs

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
214
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
346
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
667
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
461